Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.

Veure altres versions (1)

Neutralizing (nAbs) and high affinity binding antibodies may be critical for an efficacious HIV-1 vaccine. We characterized virus-specific nAbs and binding antibody responses over 21 months in eight HIV-1 subtype C chronically infected individuals with heterogeneous rates of disease progression. Aut...

Descripció completa

Dades bibliogràfiques
Autors principals:	Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
per: Archary, D, et al.
Publicat: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
per: Archary, Derseree, et al.
Publicat: (2014)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
per: Archary, D, et al.
Publicat: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
per: Archary D, et al.
Publicat: (2012-09-01)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression.
per: Archary, D, et al.
Publicat: (2010)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
per: Goulder Philip JR, et al.
Publicat: (2010-11-01)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
per: Murphy, M, et al.
Publicat: (2013)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
per: Murphy MK, et al.
Publicat: (2012-09-01)

Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
per: Murphy MK, et al.
Publicat: (2012-09-01)

Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
per: Wright, J, et al.
Publicat: (2009)

Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies
per: Hermanus T, et al.
Publicat: (2012-09-01)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
per: Megan K Murphy, et al.
Publicat: (2013-02-01)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
per: London GG, et al.
Publicat: (2012-09-01)

Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection
per: M. Muenchhoff, et al.
Publicat: (2020-12-01)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
per: Wright, J, et al.
Publicat: (2009)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
per: Goulder PJ, et al.
Publicat: (2009-10-01)

Revisiting the Influence of HLA-type, Frequency, HLA-supertype and Homozygosity on the Immune Control of HIV
per: Leslie, A, et al.
Publicat: (2008)

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
per: Rolland, M, et al.
Publicat: (2010)

Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies
per: Jenniffer M. Mabuka, et al.
Publicat: (2017-09-01)

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
per: Penny L Moore, et al.
Publicat: (2009-09-01)

Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.
per: Leslie, A, et al.
Publicat: (2010)

Harnessing the protective potential of HIV-1 neutralizing antibodies [version 1; referees: 2 approved]
per: S Abigail Smith, et al.
Publicat: (2016-01-01)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
per: Abdool-Karim S, et al.
Publicat: (2009-10-01)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
per: Amyn A. Murji, et al.
Publicat: (2021-07-01)

Limited Sequence Variation and Similar Phenotypic Characteristics of HIV-1 Subtype C Gag Variants Derived From the Reservoir and Pre-Therapy Plasma
per: Doty Ojwach, et al.
Publicat: (2022-07-01)

Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection
per: Kewreshini K. Naidoo, et al.
Publicat: (2021-09-01)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
per: Narayanaiah Cheedarla, et al.
Publicat: (2018-03-01)

Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
per: Brander, Christian, et al.
Publicat: (2011)

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
per: Morgane Rolland, et al.
Publicat: (2010-09-01)

Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.
per: Ndhlovu, Z, et al.
Publicat: (2011)

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
per: Seung E, et al.
Publicat: (2012-09-01)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
per: Madeleine F. Jennewein, et al.
Publicat: (2020-08-01)

HIV-1 DNA sequence diversity and evolution during acute subtype C infection
per: Guinevere Q. Lee, et al.
Publicat: (2019-06-01)

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
per: Basu Debby, et al.
Publicat: (2012-09-01)

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
per: Rong Rong, et al.
Publicat: (2009-09-01)

Nef genotype influences immune control in individuals living with HIV-1 who carrying protective alleles
per: F. Method Mwimanzi, et al.
Publicat: (2019-07-01)

Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal
per: Shreyal Maikoo, et al.
Publicat: (2024-12-01)

Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.
per: Hannah O Ajoge, et al.
Publicat: (2011-01-01)

PP 3.14 – 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART
per: K. Gopee, et al.
Publicat: (2022-12-01)

Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
per: Ikanyeng D Seipone, et al.
Publicat: (2018-01-01)